Oncology Clinical Trials in Norfolk, VA
As of August 2026, 57 paid clinical trials are recruiting for Oncology in Norfolk, Virginia. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
57 clinical trials for Oncology
·Clear filters·Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast Cancer
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
A Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine in Participants With Newly Diagnosed Folate Receptor Alpha (FRα)Expressing Advanced-Stage Serous Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer.
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
A Study of Disitamab Vedotin in Adults With HER2 Expressing Advanced Breast Cancer
Palazestrant in Combination With Ribociclib for the First-line Treatment of ER+/HER2- Advanced Breast Cancer
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.
A Clinical Trial of Sac-TMT in People With Non-HRD Positive Advanced Ovarian Cancer (MK-2870-021)
A Study to Evaluate the Effect of GDC-4198 Alone and in Combination With Giredestrant Versus Abemaciclib and Giredestrant in Participants With Locally Advanced or Metastatic Estrogen Receptor-Positive (ER+), Human Epidermal Growth Factor Receptor-Negative (HER2-) Breast Cancer
Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
A Study Evaluating the Safety, Activity, and Pharmacokinetics of Divarasib as a Single Agent or in Combination With Other Anti-Cancer Therapies in Participants With Previously Untreated Advanced or Metastatic Non-Small Cell Lung Cancer With a KRAS G12C Mutation
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Study of ORIC-944 in Patients With Metastatic Prostate Cancer
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
A Study of ZL-1310 in Participants With Selected Solid Tumors
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
A Clinical Trial of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) to Treat Urothelial Cancer (MK-2870-031)
Study of Patritumab Deruxtecan Plus Pembrolizumab With Other Anticancer Agents in Participants With High-Risk Early-Stage Triple-Negative or Hormone Receptor-Low Positive/HER-2 Negative Breast Cancer (MK-1022-010, HERTHENA-Breast-03)
A Study of Sacituzumab Govitecan Given at an Alternative Dose and Schedule in Participants With Advanced Triple-Negative Breast Cancer
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Top Research Study Locations in Norfolk
Researchers run research studies in Norfolk, VA at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Virginia Oncology Associates | Breast Cancer, Multiple Myeloma, Colorectal Cancer | 40 |
| Children's Hospital of The King's Daughters | Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, Duchenne Muscular Dystrophy | 40 |
| Sentara Norfolk General Hospital | Aortic Valve Stenosis, Heart Failure, Heart Failure With Reduced Ejection Fraction | 31 |
| Virginia Oncology Associates (VOA) | Breast Neoplasms, Breast Cancer, Bladder Cancer | 6 |
| Old Dominion University | Exercise, Cardiovascular (CV) Risk, Cleft Lip Palate | 5 |
| Clinical Trial Site | Breast Cancer, ER Positive Breast Cancer, HER2 Negative Breast Carcinoma | 4 |
| Eastern Virginia Medical School | Alzheimer Disease, Chronic Rhinosinusitis With Nasal Polyps (CRSwNP), Dementia | 4 |
| Sentara Health | Acute Kidney Injury, Blood Pressure, Coronary Artery Disease | 4 |
| Sentara Health Research Center | Abdominal Aortic Aneurysm (AAA), Heart Failure, Obesity | 4 |
| Virginia Eye Consultants | Corneal Scar, Neurotrophic Keratopathy, Non-infectious Anterior Uveitis | 4 |
| Virginia Pediatric Eye Center | Amblyopia, Myopia | 4 |
| Sentara Heart Hospital | AAA - Abdominal Aortic Aneurysm, Abdominal Aortic Aneurysm, Chronic Thromboembolic Pulmonary Hypertension | 3 |
| Sentara Cardiovascular Research Institute | Aortic Stenosis, Aortic Stenosis, Severe, Transthyretin Amyloid Cardiomyopathy (ATTR CM) | 3 |
| Sentara Healthcare | Heart Failure, Tricuspid Valve Disease, Cardiovascular Diseases | 3 |
| Tidewater Physicians for Women | Contraception, Healthy, RSV Infection | 3 |
| Virginia Clinical Research | Alopecia, Areata Alopecia, Hair Diseases | 3 |
| AMR Clinical - Norfolk | Acute Migraine, Migraine | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| Ascendis Investigational Site | Growth Hormone Deficiency | 2 |
| Children's Specialty Group | Crohn Disease, Narcolepsy Type 1 | 2 |
| Children's Specialty Group - 3 Commercial Place | Episodic Migraine, Migraine | 2 |
| Childrens Hospital of the Kings Daughter Norfolk | Muscular Atrophy, Spinal, Spinal Muscular Atrophy | 2 |
| Eastern Virginia Medical School - Old Dominion University | Gestational Diabetes Mellitus, Gestational Hypertension, Hypertensive Disorders of Pregnancy | 2 |
| GSK Investigational Site | Neoplasms, Non-alcoholic Fatty Liver Disease | 2 |
| Macon & Joan Brock Virginia Health Sciences at Old Dominion University | Hemolytic Disease of the Fetus and Newborn, Preeclampsia (PE) | 2 |
Active & Upcoming Studies in Norfolk (2026)
Recruiting trials in Norfolk grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (85 active studies)
- Xylitol Dental Wipes for the Reduction of Bloodstream Infection Risk in Children With Acute Myeloid Leukemia · Phase 3 · Children's Oncology Group
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer · Phase 2, Phase 3 · Pfizer
Cardiovascular (26 active studies)
- A Prospective, Randomized Multicenter Clinical Trial of the TricValve® Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation. · P+F Products + Features USA Inc.
- A Comparison of a Medication Adherence Platform (FORTISKAP™) vs. Usual Care in Subjects on Oral Medications for the Treatment of Interstitial Lung Disease, Sarcoid and Pulmonary Hypertension · Cosmos Rx, Inc
Neurology & pain (16 active studies)
- A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
- A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine · Phase 3 · Kallyope Inc.
Diabetes & metabolic (15 active studies)
- A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight · Phase 3 · AstraZeneca
- A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus · Phase 3 · AstraZeneca
Pediatric (5 active studies)
- Early Intervention in Infants With Unrepaired Cleft Palate: Language, Palatal Function, and Articulation. · Old Dominion University
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine · Phase 3 · H. Lundbeck A/S
Eye & vision (4 active studies)
- A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) · Phase 2 · Janssen Research & Development, LLC
- A Long-term Follow-up Study to Evaluate SKG0106 in the Treatment of Patients With nAMD · Skyline Therapeutics
Vaccines (1 active study)
HIV / STI (1 active study)
- PrEPwise Pilot Among Black Women in Eastern Virginia · Boston University
Common conditions studied in Norfolk
- Breast Cancer (9 active studies)
- Heart Failure (9 active studies)
- Duchenne Muscular Dystrophy (6 active studies)
- Breast Neoplasms (5 active studies)
- Multiple Myeloma (5 active studies)
- Acute Myeloid Leukemia (4 active studies)
Leading research sponsors in Norfolk
- AstraZeneca
- Children's Oncology Group
- National Cancer Institute (NCI)
- Pfizer
- Eli Lilly and Company
Frequently asked questions
How many paid clinical trials are currently recruiting in Norfolk?
There are approximately 294 recruiting clinical trials in Norfolk, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Norfolk pay participants?
Most recruiting trials in Norfolk compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Norfolk?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Norfolk?
The most common conditions under active study in Norfolk include Breast Cancer (9), Heart Failure (9), Duchenne Muscular Dystrophy (6), Breast Neoplasms (5), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Norfolk?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Norfolk on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Norfolk?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Norfolk?
Recruiting research sites in Norfolk include Virginia Oncology Associates, Children's Hospital of The King's Daughters, Sentara Norfolk General Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Norfolk right now?
The largest active categories in Norfolk are Cancer & tumors (85), Cardiovascular (26), Neurology & pain (16). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.